Valeant Pharmaceuticals (VRX) volatility stays elevated after less than expected Q3 and outlook

Valeant Pharma (NYSE: VRX) November weekly call option implied volatility is at 142, November is at 116, December is at 95; compared to its 52-week range of 53 to 173 after reporting less than expected Q3 results and outlook

You May Also Be Interested In

• Netflix (NFLX) April option implied volatility increases into quarter results
• Teucrium Corn Fund (CORN) call put ratio 18 calls to 1 put with focus on May 20 calls
• Schlumberger (SLB) option IV elevated into quarter results and outlook